L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 67,200
+600 (0.90%)
Dec 10, 2025, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.64 trillion as of December 10, 2025. Its market cap has increased by 338.85% in one year.
Market Cap
1.64T
Enterprise Value
1.70T
Revenue
79.99B
Ranking
n/a
PE Ratio
21.64
Stock Price
67,200.00
Market Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.64T, an increase of 740.98%. That is a compound annual growth rate of 34.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 1.64T | 199.91% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | 754.76B | 300.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.44T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| HLB Co., Ltd. | 6.53T |